Logo LenioBio GmbH.png

LenioBio GmbH

Founded in 2016 as a lifescience biotech company, LenioBio is a protein expression platform company committed to the advancement of transformative technology for the discovery, development, and large-scale production of proteins, unconstrained by the limitations of the cell. We strongly believe in the power of proteins and will be introducing a range of tools for rapid, scalable and reliable expression of any protein. Our solution called ALiCE is the first eukariyotic cell-free platform and is the concentrated protein machinery of the cell. Born from our dream to produce enough Ebola vaccines our goal is to simplify manufacturing and speed up the delivery of drugs to the patient.